Watson Announces Positive Data For Its New Investigational Products For Benign Prostatic...

medicalnewstoday.com     May 22, 2008            

Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that investigators presented clinical data on two Phase 3 products at the American Urological Association's annual meeting. The abstract (Steady-State Pharmacokinetics of an Investigational... [read full story]                    


*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies